Authors report producing anti-PD-1 monoclonal antibody nivolumab using an innovative mRNA platform, highlighting its potential in therapy.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Pereira et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: